ImmunoGen, Inc.
Records under this name other than the patents ImmunoGen, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 119 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,163,736 | Cytotoxic Agents Comprising New Tomaymycin Derivatives Formerly held In force · High confidence | In force | High confidence | |
| US 8,404,678 | Cytotoxic Agents Comprising New Tomaymycin Derivatives and Their Therapeutic Use Formerly held In force · High confidence | In force | High confidence | |
| US 9,370,584 | CA6 Antigen-Specific Cytotoxic Conjugate and Methods of Using the Same Formerly held In force · High confidence | In force | High confidence | |
| US 8,668,910 | Antibodies That Specifically Bind to the EPHA2 Receptor Formerly held In force · High confidence | In force | High confidence | |
| US 9,676,864 | Antibodies That Specifically Bind to the EPHA2 Receptor Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 10,202,460 | CD37-Binding Molecules and Immunoconjugates Thereof Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 9,314,522 | Antitumors Combinations Containing Antibodies Recognizing Specifically CD38 And Bortezomib Formerly held In force · High confidence | In force | High confidence | |
| US 9,346,887 | CD37-Binding Molecules and Immunoconjugates Thereof Formerly held In force · High confidence | In force | High confidence | |
| US 11,466,095 | CD37-Binding Molecules and Immunoconjugates Thereof Formerly held In force · High confidence | In force | High confidence | |
| US 8,765,917 | CD37-Binding Molecules and Immunoconjugates Thereof Formerly held In force · High confidence | In force | High confidence |